ebook Munafa Stock Market Course + Intraday & FNO calls  

       

APLS announcements Apellis Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Apellis Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Apellis Pharmaceuticals, Inc. APLS

Apellis Pharmaceuticals, Inc. APLS listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Apellis Pharmaceuticals, Inc. APLS

Why Apellis Pharmaceuticals Wilted on Wednesday
A big quarterly earnings miss was the news driving down the value of Apellis Pharmaceuticals (NASDAQ: APLS) stock in the middle of the trading week. Investors didn't take this development well, and they collectively pushed down Apellis by almost 6%, on a d
Announcement as on 07 May 2025

Relative Strength Alert For Apellis Pharmaceuticals
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength
Announcement as on 17 April 2024

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?
Apellis Pharmaceuticals, Inc. (APLS) shares ended the last trading session 14.7% higher at .35. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to t
Announcement as on 09 January 2024

Apellis Pharmaceuticals’ stock slides 14% after company gets negative trend vote for eye treatment in Europe

Announcement as on 14 December 2023

: Apellis Pharmaceuticals shares rally as competing eye treatment fails to impress analysts
Apellis Pharmaceuticals Inc. shares APLS jumped 8% premarket on Tuesday after competitor Iveric Bio, a unit of Astellas Pharma Inc. ALPMY, on Monday released results of a trial of Izervay as a treatment for geographic atrophy, a form of age-related macular
Announcement as on 19 September 2023

Announcements by Apellis Pharmaceuticals, Inc. first page | Next page |

APLS Apellis Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Apellis Pharmaceuticals, Inc.

  • 5Day Average: 21.32
  • 12Day Average: 20.64
  • 20Day Average: 20.27
  • 50Day Average: 22.92
  • 100Day Average: 23.65
  • 150Day Average: 21.86
  • 200Day Average: 22.01

APLS Indicators & signals

Indicator MACD (12,26,9)

21.02, 21.47, -0.83
Indicator MACD is in negative zone

Indicator ADX (14)

4, 25.74, 23.76
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of APLS Apellis Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Thu Dec 2025 22.19 21.16 to 22.45 4.42% 1.29 times
03 Wed Dec 2025 21.25 20.61 to 21.32 2.86% 0.78 times
02 Tue Dec 2025 20.66 20.51 to 21.34 -2.55% 0.85 times
01 Mon Dec 2025 21.20 21.00 to 21.38 -0.47% 0.79 times
28 Fri Nov 2025 21.30 21.11 to 21.72 -1.34% 0.53 times
26 Wed Nov 2025 21.59 20.90 to 21.71 2.81% 0.92 times
25 Tue Nov 2025 21.00 19.99 to 21.14 4.32% 1.16 times
24 Mon Nov 2025 20.13 19.50 to 20.35 2.65% 2.08 times
21 Fri Nov 2025 19.61 19.40 to 19.95 0.36% 0.73 times
20 Thu Nov 2025 19.54 19.48 to 19.91 0.46% 1.15 times
19 Wed Nov 2025 19.45 19.31 to 19.83 -1.42% 1.01 times
18 Tue Nov 2025 19.73 19.68 to 20.21 -1.84% 1.09 times

Videos related to: APLS announcements Apellis Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

APLS announcements Apellis Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top